NCT00441090 · Interventional trial
Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Overall registry status Completed
Phase 2
Conditions Chronic Idiopathic Thrombocytopenic Purpura, Purpura, Thrombocytopenic, Idiopathic
Delaware Valley sites
- UPENN · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory